Megan O'grady, PSYD | |
600 E 5th St, Fulton, MO 65251-1753 | |
(573) 592-2613 | |
Not Available |
Full Name | Megan O'grady |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 600 E 5th St, Fulton, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275075418 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 2016016757 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Megan O'grady, PSYD 600 E 5th St, Fulton, MO 65251-1753 Ph: (573) 592-2613 | Megan O'grady, PSYD 600 E 5th St, Fulton, MO 65251-1753 Ph: (573) 592-2613 |
News Archive
MolecularMD Corp announced today that it has moved their core operations to a expanded dedicated facility with capacity and functionality to support the expansion of its cancer molecular diagnostics business.
Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose. Opioids are a class of drugs that include prescription medications such as oxycodone, hydrocodone, and morphine, as well as the illegal drug heroin.
Three articles published in JAMA Oncology highlight the legal and clinical care issues surrounding fertility preservation in US patients with cancer.
In a study published today in the International Journal of Cancer, Gen-Probe's APTIMA HPV Assay provided a better combination of sensitivity and specificity than HPV DNA- or cytology-based tests for cervical cancer screening.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.
› Verified 6 days ago
Bryan Zolnikov, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623 Fax: 573-592-3001 | |
Dr. Jeffrey R Nolting, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2195 | |
Eric Martin, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623 | |
Dr. Sharon Robbins, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-3365 | |
Kirsten Deming Hunter, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623 | |
James Bridges, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 600 E 5th St, Fulton, MO 65251 Phone: 573-592-2623 |